Disease, N.I.o.D.a.D.a.K. What is diabetes? 2023 [cited 2023 October 20]; Available from: https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes.
Zhang S, Staples AE. Microfluidic-based systems for the management of diabetes. Drug Deliv Transl Res. 2024;14:2989.
Article CAS PubMed PubMed Central Google Scholar
Saeedi P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9. Diabetes Res Clin Pract. 2019;157: 107843.
Saeedi P, et al. Mortality attributable to diabetes in 20–79 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9. Diabetes Res Clin Pract. 2020;162: 108086.
Mobasseri M, et al. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98–115.
Article PubMed PubMed Central Google Scholar
Collaborators GD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: asystematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023;402(10397):31.
Di Pietrantonio N, et al. Role of epigenetics and metabolomics in predicting endothelial dysfunction in type 2 diabetes. Adv Biol (Weinh). 2023;7(9): e2300172.
Nørlev JTD, et al. Quantification of insulin adherence in adults with insulin-treated type 2 diabetes: a systematic review. Diabetes Metab Syndr. 2023;17(12): 102908.
Li SH, et al. Metal-polyphenol microgels for oral delivery of puerarin to alleviate the onset of diabetes. Drug Deliv Transl Res. 2024;14(3):757–72.
Article CAS PubMed Google Scholar
Tan SY, et al. Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr. 2019;13(1):364–72.
Yoon J-W, Jun H-S. Recent advances in insulin gene therapy for type 1 diabetes. Trends Mol Med. 2002;8(2):6.
Kono TM, et al. Human adipose-derived stromal/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectors. Stem Cells. 2014;32(7):1831–42.
Article CAS PubMed Google Scholar
Sher EK, et al. Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy—a review. Diabetes Metab Syndr. 2023;17(11): 102901.
Article CAS PubMed Google Scholar
El Maalouf IR, Capoccia K, Priefer R. Non-invasive ways of administering insulin. Diabetes Metab Syndr. 2022;16(4): 102478.
Lopes M, et al. Why most oral insulin formulations do not reach clinical trials. Ther Deliv. 2015;6(8):973–87.
Article CAS PubMed Google Scholar
Arora S, et al. Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus. Prim Care Diabetes. 2021;15(5):859–64.
Article CAS PubMed Google Scholar
Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661–7.
Hammad RW, et al. Cubosomal functionalized block copolymer platform for dual delivery of linagliptin and empagliflozin: recent advances in synergistic strategies for maximizing control of high-risk type II diabetes. Drug Deliv Transl Res. 2024;14(3):678–95.
Article CAS PubMed Google Scholar
Trief PM, et al. Incorrect insulin administration: a problem that warrants attention. Clin Diabetes. 2016;34(1):25–33.
Article PubMed PubMed Central Google Scholar
DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet J. 2018;391(10138):2449–62.
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.
Pandey V, et al. Chapter 18—excipient toxicity and safety. In: Tekade RK, editor., et al., Pharmacokinetics and toxicokinetic considerations. New York: Academic Press; 2022. p. 487–511.
Sharma S, Parveen R, Chatterji BP. Toxicology of nanoparticles in drug delivery. Curr Pathobiol Rep. 2021;9(4):133–44.
Article CAS PubMed PubMed Central Google Scholar
Gil AG, et al. Toxicity and biodistribution of orally administered casein nanoparticles. Food Chem Toxicol. 2017;106(Pt A):477–86.
Article CAS PubMed Google Scholar
Harugade A, Sherje A, Pethe A. Chitosan: a review on properties, biological activities and recent progress in biomedical applications. React Funct Polym. 2023;1991.
Wang W, et al. Chitosan derivatives and their application in biomedicine. Int J Mol Sci. 2020;21(2):487.
Article PubMed PubMed Central Google Scholar
Xu J, et al. Chitosan-microcapsulated insulin alleviates mesenteric microcirculation dysfunction via modulating COX-2 and VCAM-1 expression in rats with diabetes mellitus. Int J Nanomed. 2018;13:6829–37.
Tian H, et al. Uniform core–shell nanoparticles with thiolated hyaluronic acid coating to enhance oral delivery of insulin. Adv Healthc Mater. 2018;7(17): e1800285.
Agrawal A, et al. Folate appended chitosan nanoparticles augment the stability, bioavailability and efficacy of insulin in diabetic rats following oral administration. RSC Adv. 2015;5:105179–93.
Papakostidis C, Giannoudis PV. Meta-analysis. What have we learned? Injury. 2023;54(Suppl 3):S30–4.
Wang XM, et al. A brief introduction of meta-analyses in clinical practice and research. J Gene Med. 2021;23(5): e3312.
Article PubMed PubMed Central Google Scholar
Peng T, et al. Rational design of oral delivery nanosystems for hypoglycemic peptides. Nano Today. 2023;53: 102031.
Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.
Article PubMed PubMed Central Google Scholar
Morgan RL, et al. Identifying the PECO: a framework for formulating good questions to explore the association of environmental and other exposures with health outcomes. Environ Int. 2018;121(Pt 1):1027–31.
Article PubMed PubMed Central Google Scholar
Guyatt GH, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395–400.
Ouzzani M, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.
Article PubMed PubMed Central Google Scholar
Tiloke C, Phulukdaree A, Chuturgoon AA. The chemotherapeutic potential of gold nanoparticles against human carcinomas: a review. In: Andrew W, editor. Nanoarchitectonics for smart delivery and drug targeting. New York: Elsevier; 2016. p. 783–811.
留言 (0)